You're reading the free version. Trader adds the live tape and alerts.
Start tracking
URGN Exercise Disclosure
Schoenberg Mark · SEC Form 4 · Filed Sep 9, 2026
Exercise
Reported value range
Not reported
Schoenberg Mark Chief Medical Officer
URGN
UroGen Pharma Ltd
URGN
Transaction date
Sep 7, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 2 days later
URGN daily price context
Close on/before transaction
$44.09
Sep 7, 2026
First close after public filing
$45
Sep 9, 2026
30-day return after filing
-18.16%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 1,667 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-029965
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$37.38K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Urogen Pharma Ltd. URGN | Sale | Sep 8, 2026 | $37.38K |
| Urogen Pharma Ltd. URGN | Exercise | Sep 7, 2026 | $0 |
| Urogen Pharma Ltd. URGN Current | Exercise | Sep 7, 2026 | Not reported |